Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.82
-0.05 (-5.75%)
At close: Aug 19, 2025, 1:48 PM

Iterum Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 2.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
696K 342K 239K n/a 8K 7K 440K 436K 438K 436K 439K 448K 455K 458K 1.77M 111K 185K n/a
Gross Profit
-696K -342K -239K n/a -8K -7K -440K -436K -438K -436K -439K -448K -455K -458K -1.77M -111K -185K -35K
Operating Income
-5.53M -3.71M -3.67M -4.89M -3.98M -6.16M -11.43M -16.68M -10.82M -8.53M -7.93M -7.03M -8.05M -7.37M -6.83M -4.87M -6.99M -5.85M
Interest Income
133K n/a n/a n/a n/a n/a n/a n/a 324.00 399.00 80.00 636.00 n/a n/a n/a n/a n/a n/a
Pretax Income
-6.45M -4.83M -6.56M -5.96M -4.97M -7.05M -12.22M -3.72M -12.06M -9.77M -4.99M -29.68M -6.39M -3.07M -4.01M 4.09M 7.92M -98.86M
Net Income
-6.51M -4.89M -6.58M -6.09M -5M -7.1M -12.36M -3.88M -12.24M -9.89M -5.09M -29.11M -6.74M -3.5M -4.18M 3.74M 7.8M -98.92M
Selling & General & Admin
4.18M 2.78M 2.12M 1.78M 1.9M 2.19M 1.69M 1.83M 1.86M 2.1M 2.09M 2.68M 4.07M 3.93M 3.13M 3.03M 4.27M 3.4M
Research & Development
649K 591K 1.31M 3.11M 2.08M 3.97M 9.3M 14.85M 8.96M 6.43M 5.84M 4.35M 3.98M 3.44M 3.7M 1.84M 2.71M 2.45M
Other Expenses
n/a n/a n/a n/a n/a -17K -79K 70K 50K 41K -103K -17.18M 269K 162K 28K 33K 93K 41K
Operating Expenses
4.83M 3.37M 3.42M 4.89M 3.98M 6.16M 10.99M 16.68M 10.82M 8.53M 7.93M 7.03M 8.05M 7.37M 6.83M 4.87M 6.99M 5.85M
Interest Expense
449K 534K -4.17M 590K 571K 487K 405K 300K 324K 399K n/a 636K 766K 1.04M 772K 849K 980K 2.95M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.53M 3.71M 3.67M 4.89M 3.98M 6.16M 11.43M 16.68M 10.82M 8.53M 7.93M 7.03M 8.05M 7.37M 6.83M 4.87M 6.99M 5.85M
Income Tax Expense
59K 60K 25K 136K 31K 48K 142K 161K 187K 123K 101K -570K 343K 427K 171K 352K 122K 60K
Shares Outstanding (Basic)
39.94M 34.06M 19.7M 20.04M 16.55M 15.43M 13.18M 13.04M 12.94M 12.68M 13.34M 12.23M 12.22M 13.23M 13.22M 12.18M 13.02M 8.79M
Shares Outstanding (Diluted)
39.94M 34.06M 19.7M 20.04M 16.55M 15.43M 13.18M 13.04M 12.94M 12.68M 13.34M 12.23M 12.22M 12.19M 13.22M 13.48M 13.64M 8.1M
EPS (Basic)
-0.16 -0.14 -0.25 -0.3 -0.3 -0.46 -0.94 -0.3 -0.95 -0.78 -0.41 -2.38 -0.55 -0.29 -0.34 0.29 0.60 -12.21
EPS (Diluted)
-0.16 -0.14 -0.25 -0.3 -0.3 -0.46 -0.94 -0.3 -0.95 -0.78 -0.41 -2.38 -0.55 -0.29 -0.34 0.28 0.55 -11.2
EBITDA
-5.65M -3.95M -5.42M -5.36M -4.39M -6.56M -11.38M -2.98M -11.29M -8.93M -4.63M -28.59M -5.17M -1.58M -1.47M 5.05M 9.09M -95.87M
EBIT
-6M -4.3M -5.68M -5.37M -4.39M -6.57M -11.81M -3.42M -11.73M -9.37M -4.99M -29.04M -5.63M -2.03M -3.24M 4.94M 8.9M -95.91M
Depreciation & Amortization
351K 349K 261K 8K 8K 7K 440K 436K 438K 436K 439K 448K 455K 458K 1.77M 111K 185K 35K